82 related articles for article (PubMed ID: 16084352)
1. New antithrombotics in the prevention of thromboembolic disease.
Yavin YY; Wolozinsky M; Cohen AT
Eur J Intern Med; 2005 Aug; 16(4):257-66. PubMed ID: 16084352
[TBL] [Abstract][Full Text] [Related]
2. Emerging anticoagulants: mechanism of action and future potential.
Klement P; Rak J
Vnitr Lek; 2006 Mar; 52 Suppl 1():119-22. PubMed ID: 16637459
[TBL] [Abstract][Full Text] [Related]
3. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
4. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
[TBL] [Abstract][Full Text] [Related]
5. New anticoagulants for venous thromboembolic disease.
Chang P
IDrugs; 2004 Jan; 7(1):50-7. PubMed ID: 14730467
[TBL] [Abstract][Full Text] [Related]
6. [New anticoagulants].
Kawasaki T; Hirayama F
Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):275-82. PubMed ID: 11215377
[TBL] [Abstract][Full Text] [Related]
7. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
Savelieva I; Bajpai A; Camm AJ
Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
[TBL] [Abstract][Full Text] [Related]
8. New anticoagulants: current status and future potential.
Weitz JI; Crowther MA
Am J Cardiovasc Drugs; 2003; 3(3):201-9. PubMed ID: 14727932
[TBL] [Abstract][Full Text] [Related]
9. New parenteral anticoagulants in development.
Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Rocha E; Pozo-Hernández C; Vargas-Castrillón E
Ther Adv Cardiovasc Dis; 2011 Feb; 5(1):33-59. PubMed ID: 21045018
[TBL] [Abstract][Full Text] [Related]
10. [What is new in antithrombotic treatment?].
Mikdame M; Kharchafi A; Toloune F; Archane MI
Ann Biol Clin (Paris); 2002; 60(2):131-41. PubMed ID: 11937438
[TBL] [Abstract][Full Text] [Related]
11. Novel anticoagulants in clinical development: focus on factor Xa and direct thrombin inhibitors.
Steffel J; Lüscher TF
J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):616-23. PubMed ID: 19561526
[TBL] [Abstract][Full Text] [Related]
12. Recombinant activated factor VII effectively reverses the anticoagulant effects of heparin, enoxaparin, fondaparinux, argatroban, and bivalirudin ex vivo as measured using thromboelastography.
Young G; Yonekawa KE; Nakagawa PA; Blain RC; Lovejoy AE; Nugent DJ
Blood Coagul Fibrinolysis; 2007 Sep; 18(6):547-53. PubMed ID: 17762530
[TBL] [Abstract][Full Text] [Related]
13. Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke.
Martí-Fàbregas J; Mateo J
Cerebrovasc Dis; 2009; 27 Suppl 1():111-9. PubMed ID: 19342840
[TBL] [Abstract][Full Text] [Related]
14. Role of current and emerging antithrombotics in thrombosis and cancer.
Mousa SA
Timely Top Med Cardiovasc Dis; 2006 Aug; 10():E19. PubMed ID: 17066136
[TBL] [Abstract][Full Text] [Related]
15. New antithrombotics in the treatment of thromboembolic disease.
Levi M
Eur J Intern Med; 2005 Aug; 16(4):230-7. PubMed ID: 16084349
[TBL] [Abstract][Full Text] [Related]
16. New anticoagulants.
Bauer KA
Curr Opin Hematol; 2008 Sep; 15(5):509-15. PubMed ID: 18695376
[TBL] [Abstract][Full Text] [Related]
17. New antithrombotic agents.
Castelli R; Porro F; Savo D; Cassinerio E
Panminerva Med; 2006 Dec; 48(4):247-56. PubMed ID: 17215797
[TBL] [Abstract][Full Text] [Related]
18. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulant drugs: an update.
Kwaan HC; Samama MM
Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):511-22. PubMed ID: 15225111
[TBL] [Abstract][Full Text] [Related]
20. Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases.
Turpie AG
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1238-47. PubMed ID: 17379841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
